GdDTPA-enhanced magnetic resonance imaging of the aqueous flow in the rabbit eye
✍ Scribed by Hong-Ming Cheng; Kenneth K. Kwong; Jing Xiong; Chen Chang
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 358 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0740-3194
No coin nor oath required. For personal study only.
✦ Synopsis
Magnetic resonance imaging with gadolinium-diethylenetriaminepentaacetic acid complex (GdDTPA) as the contrast agent was used to image the aqueous chamber of the eye. This method, in addition to providing spatial information, permits quantitative study of the aqueous flow. GdDTPA solution was applied either topically or intravenously, entering the anterior chamber via different pathways. The wash-in and wash-out of GdDTPA follow a two-compartment model which enables determination of the aqueous flow rate by multiplying the aqueous chamber volume by the wash-out rate constant. Rabbit eyes showed a flow rate of 1.5-2 microliters/min which was retarded by the systemic administration of acetazolamide (Diamox).
📜 SIMILAR VOLUMES
## Abstract ## Purpose: To investigate the short‐term reproducibility of black‐blood dynamic contrast‐enhanced (DCE) magnetic resonance imaging (MRI) in atherosclerotic rabbits to evaluate the potential of this technique to be a reliable readout of plaque progression and/or regression upon therape
Manipulation of the data describing two-dimensional magnetic resonance (MR) images can be used to zoom an image, decrease image noise and artifacts by modeling, or emphasize object edges in the field of view. In this paper, a two-dimensional band-selectable digital filtering (2D-BSDF) technique is d
## Abstract We report a case of histologically proven primary leiomyoma of the liver that was evaluated with multiphasic 64‐section computed tomography (CT) and gadobenate dimeglumine–enhanced magnetic resonance (MR) imaging. This lesion showed vivid enhancement during the arterial phase with susta
The quantitation of in vivo 1 H MR spectroscopy and dynamic contrast enhanced MR imaging is described for patients with histologically confirmed prostate adenocarcinoma and benign prostatic hypertrophy (BPH). Results are presented which suggest that combined use of these techniques may be helpful in